Posts

Showing posts from November, 2021

Lexapro (Escitalopram) Oral: Uses, Side Effects, Dosages - Verywell Health

Image
What Is Lexapro? Lexapro (escitalopram) is a prescription medication used to treat depression and generalized anxiety disorder. It is referred to as an antidepressant and classified as a selective serotonin reuptake inhibitor (SSRI). Lexapro is thought to improve mood by increasing levels of the neurotransmitter in the brain called serotonin. Although generally safe to take, Lexapro does have a boxed warning, the most serious warning from the Food and Drug Administration (FDA), for the risk of suicidal thinking and behavior in children, adolescents, and young adults. Taking antidepressants for major depressive disorder and other disorders can increase this risk in these patients. However, Lexapro is not approved for use in children less than 12 years of age. Drug Facts Generic Name: Escitalopram Brand Name(s): Lexapro Administration Route(s): Oral Drug Availability: Prescription Therapeutic Classification: Antidepressant Available Generically: Ye

Daily Medication Pearl: Voltaren (Diclofenac Sodium Topical Gel) for Osteoarthritis - Pharmacy Times

Image
Voltaren treats osteoarthritis pain in the joints amenable to topical treatment, such as the knees and the hands. Medication Pearl of the Day: Voltaren (Diclofenac Sodium Topical Gel) Indication: Voltaren gel is a non-steroidal anti-inflammatory drug indicated for relief of from the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and the hands. Insight: Dosing: Apply Voltaren (2 to 4 g) to the affected area 4 times daily. Total dose should not exceed 32 g per day. Dosage form: Voltaren gel (diclofenac sodium topical gel), 1%. Adverse events (AEs): Most common AEs (incidence >2% of patients treated with Voltaren and greater than placebo) are application site reactions, including dermatitis. Mechanism of action : Diclofenac has analgesic, anti-inflammatory, and antipyretic properties. Manufacturer: Endo Pharmaceuticals Sources:

Medicaid and CHIP Services Information for Providers | Texas Health and Human Services - Texas Health and Human Services |

Medicaid CHIP COVID-19 Information Sessions Beginning May 6, 2021, HHSC will post pre-recorded sessions monthly. These sessions will continue to share information with stakeholders about the implementation of various Medicaid/CHIP flexibilities in response to the COVID-19 pandemic. HHSC may return to weekly sessions as needed if there are changes to the public health emergency. WHEN:  Nov. 4, 2021 Dec. 2, 2021 Medicaid and CHIP Flexibilities Any changes to Medicaid and CHIP services will be posted here and sent out through standard communication channels. Be sure to check health plan provider portals, the TMHP COVID-19 page, and read any emails you get from HHSC. As noted in the sections below, multiple Medicaid and CHIP flexibilities have been extended through December 31, 2021. More information will be provided if there are changes. Testing for COVID-19 Healthcare providers should coordinate with local public health authorities to

Tysabri Side Effects: What They Are and How to Manage Them - Healthline

Image
If you have multiple sclerosis (MS) or Crohn's disease, your doctor might suggest Tysabri (natalizumab) as a treatment option. Along with other factors to consider, you may be wondering about the medication's possible side effects. Tysabri is a prescription biologic drug that's used to treat MS and Crohn's disease in adults. A healthcare professional will give you Tysabri as an intravenous (IV) infusion. This is an injection that slowly drips into your vein over a period of time. Tysabri infusions usually take about an hour. Tysabri is usually given once every 4 weeks. It's meant to be used as a long-term treatment. For more information about Tysabri, including details about its uses, see this in-depth article on the drug. Like other drugs, Tysabri infusions can cause mild or serious side effects. Keep reading to learn more. Some people may experience mild or serious side effects during their Tysabri treatment. These side effects can vary depending on what conditio

Betaxolol Market with Size, Share, Growth Insight, Trend, future Technology at 5.2% CAGR Dynamics and Industry Overview 2027 - Medgadget

Image
Betaxolol Market – Global Industry Insights, Trends, Opportunity Analysis, 2021-2027 the new research from Coherent Market Insights has announced report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The Betaxolol Market offers a summary of product specification, production analysis, technology, product type, considering key features such as gross margin, revenue & cost. Betaxolol Market report provides key statistics on the Market status of the Betaxolol manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1781 Betaxolol is the beta-adrenergic receptor inhibitor and racemic mixture used for treatment of patients having ocular hypertension or chronic open-angle glaucoma. It was initially appro